The impact of Oncotype DX testing on breast cancer management and chemotherapy prescribing patterns in a tertiary referral centre.

The impact of Oncotype DX testing on breast cancer management and chemotherapy prescribing patterns in a tertiary referral centre.

Item
http://www.wikidata.org/entity/Q34376320
Designing a broad-spectrum integrative approach for cancer prevention and treatment.Clinical use of the Oncotype DX genomic test to guide treatment decisions for patients with invasive breast cancer.Intraoperative radiotherapy in early stage breast cancer: potential indications and evidence to date.Impact of Oncotype DX Recurrence Score on Treatment Decisions: Results of a Prospective Multicenter Study in Turkey.Breast cancer multigene testing trends and impact on chemotherapy use.Antibody-Guided In Vivo Imaging for Early Detection of Mammary Gland Tumors.p16 overexpression and 9p21 deletion are linked to unfavorable tumor phenotype in breast cancer.Methods for Studying MicroRNA Expression and Their Targets in Formalin-Fixed, Paraffin-Embedded (FFPE) Breast Cancer Tissues.Axillary Ultrasound Accurately Excludes Clinically Significant Lymph Node Disease in Patients With Early Stage Breast Cancer.Scientific Achievements May Not Reach Everyone: Understanding Disparities in Acute Leukemia.Integration of advances in social media and mHealth technology are pivotal to successful cancer prevention and control.Tumor DNA: an emerging biomarker in head and neck cancer.Changes over time in the impact of gene-expression profiles on the administration of adjuvant chemotherapy in estrogen receptor positive early stage breast cancer patients: A nationwide study.Using a gene expression signature when controversy exists regarding the indication for adjuvant systemic treatment reduces the proportion of patients receiving adjuvant chemotherapy: a nationwide study.Economic impact of 21-gene recurrence score testing on early-stage breast cancer in Ireland.
P2860

The impact of Oncotype DX testing on breast cancer management and chemotherapy prescribing patterns in a tertiary referral centre.

Item
http://www.wikidata.org/entity/Q34376320
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The impact of Oncotype DX test ...... in a tertiary referral centre.
@ast
The impact of Oncotype DX test ...... in a tertiary referral centre.
@en
The impact of Oncotype DX test ...... in a tertiary referral centre.
@nl
type
label
The impact of Oncotype DX test ...... in a tertiary referral centre.
@ast
The impact of Oncotype DX test ...... in a tertiary referral centre.
@en
The impact of Oncotype DX test ...... in a tertiary referral centre.
@nl
prefLabel
The impact of Oncotype DX test ...... in a tertiary referral centre.
@ast
The impact of Oncotype DX test ...... in a tertiary referral centre.
@en
The impact of Oncotype DX test ...... in a tertiary referral centre.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
The impact of Oncotype DX test ...... in a tertiary referral centre.
@en
P2093
P2860
P304
P31
P356
10.1016/J.EJCA.2014.08.002
P433
P478
P50
P577
P5875
P698
P921
P932